Salem Radio Network News Friday, June 22, 2018

Health

U.S. FDA approves AstraZeneca’s asthma drug

(Reuters) – Anglo-Swedish pharmaceutical firm AstraZeneca Plc on Tuesday said the U.S. Food and Drug Administration approved its drug benralizumab, as an add-on treatment for patients with severe asthma aged 12 years and older.

The asthma drug will be marketed under the name Fasenra in the United States.

Fasenra is under regulatory review in the EU, Japan and several other countries, the company said.

Previous
Next
AdvertisementAdvertise with Us
Advertisement
Advertisement

Editorial Cartoons

View More » 1528745514776930V6Dv4UV0tP

Michael Ramirez
Mon, Jun 11, 2018

Advertisement
Advertisement
Advertisement
X CLOSE